Ketamine has an unparalleled safety profile when used for dissociative sedation as well as analgesia. Despite this, it remains a controversial agent in certain settings – sometimes due to a misunderstanding of so called “contraindications.”
In this presentation the origins of the myths of Ketamine’s “contraindications” will be explored and “debunked.” At the end of this session, practitioners will be armed with the evidence to support safe utilization of Ketamine across a spectrum of ages and indications.
James (Jim) Homme is MD and FACEP Assistant Professor of Pediatrics and Emergency Medicine at the Mayo Clinic College of Medicine. He is also Program Director – Emergency Medicine Residency, and board certified in Pediatrics and Emergency Medicine.